Medical Cannabis Payment Solutions, Inc. (REFG)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 21.91 Thousand | 21.91 Thousand | 12.65 Thousand | 2836.00 | - | - |
| Gross Profit | -21.91 Thousand | -21.91 Thousand | -12.65 Thousand | -2836.00 | - | - |
| Operating Expenses | 12.18 Thousand | 1.72 Million | 496.37 Thousand | 563 Thousand | 340.71 Thousand | 4.23 Million |
| Selling, General and Administrative Expenses | 12.18 Thousand | 1.6 Million | 496.37 Thousand | 230.4 Thousand | 340.71 Thousand | 4.23 Million |
| Research and Development Expenses | - | 120 Thousand | - | 332.6 Thousand | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 34.1 Thousand | 1.75 Million | 509.03 Thousand | 565.83 Thousand | 340.71 Thousand | 4.23 Million |
| Operating Income | -34.1 Thousand | -1.75 Million | -509.03 Thousand | -565.84 Thousand | -340.71 Thousand | -4.23 Million |
| Interest Expense | - | 420.00 | 10.03 Thousand | 1153.00 | 1000.00 | - |
| Income Tax Expense | 3.00 | 2.00 | -185.26 Thousand | 259.87 Thousand | -161.14 Thousand | -63.16 Thousand |
| Earnings before Tax | -34.1 Thousand | -1.6 Million | -333.79 Thousand | -826.86 Thousand | -1.34 Million | -4.23 Million |
| Net Income | -34.1 Thousand | -1.6 Million | -333.79 Thousand | -826.86 Thousand | -1.34 Million | -4.23 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.02 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.02 |
| Weighted Average Shares Outstanding | 608.37 Million | 608.37 Million | 544.08 Million | 473.46 Million | 458.45 Million | 240.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 608.37 Million | 608.37 Million | 544.08 Million | 473.46 Million | 458.45 Million | 240.59 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -12.18 Thousand | -1.58 Million | -311.1 Thousand | -562.99 Thousand | -1.33 Million | -4.23 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | 5479.00 | 21.91 Thousand | 5480.00 | 5479.00 |
| Gross Profit | - | - | -5479.00 | -21.91 Thousand | -5480.00 | -5479.00 |
| Operating Expenses | - | - | -1.00 | 12.18 Thousand | 300.00 | 3201.00 |
| Selling, General and Administrative Expenses | - | - | - | - | 300.00 | 3201.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | -1.00 | - | - | - |
| Cost and Expenses | - | - | 5479.00 | 34.1 Thousand | 5780.00 | 8680.00 |
| Operating Income | - | - | -5480.00 | -34.1 Thousand | -5780.00 | -8680.00 |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | - | 3.00 | - | 1.00 |
| Earnings before Tax | - | - | -5479.00 | -34.1 Thousand | -5780.00 | -8680.00 |
| Net Income | - | - | -5479.00 | -34.1 Thousand | -5780.00 | -8680.00 |
| Earnings Per Share Basic | - | - | - | - | - | - |
| Earnings Per Share Diluted | - | - | - | - | - | - |
| Weighted Average Shares Outstanding | - | - | 608.37 Million | 608.37 Million | 608.37 Million | 608.37 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | 608.37 Million | 608.37 Million | 608.37 Million | 608.37 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | -1.00 | - | -300.00 | -3200.00 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
8130
PCNT
PSGO
SELG
ALX
ARKO